Prescription drug · ANDA
Terazosin hydrochloride NDC 68788-9817
Terazosin hydrochloride 1 mg/1 · Capsule · Oral · Preferred Pharmaceuticals, Inc
NDC codes
FDA NDC DirectoryProduct NDC (as listed)68788-9817Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68788-9817Add the package segment from the table below.
| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68788-9817-1 | 6878898170168788981701 | 100 CAPSULE in 1 BOTTLE (68788-9817-1)Marketed from Apr 5, 2012 | |
| 68788-9817-3 | 6878898170368788981703 | 30 CAPSULE in 1 BOTTLE (68788-9817-3)Marketed from Apr 5, 2012 | |
| 68788-9817-6 | 6878898170668788981706 | 60 CAPSULE in 1 BOTTLE (68788-9817-6)Marketed from Apr 5, 2012 | |
| 68788-9817-9 | 6878898170968788981709 | 90 CAPSULE in 1 BOTTLE (68788-9817-9)Marketed from Apr 5, 2012 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terazosin hydrochloride
- Generic name (nonproprietary)
- terazosin hydrochloride
- Active ingredients
- Terazosin hydrochloride — 1 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Preferred Pharmaceuticals, IncNDC labeler code 68788
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075317
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 68788-9817_22a5c8ce-fac9-4cca-ad67-a7dff1c9203eSPL ID 22a5c8ce-fac9-4cca-ad67-a7dff1c9203e
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468788981701followed by a unit qualifier and the quantityPackage 68788-9817-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 68788-9817
- What is NDC 68788-9817?
- 68788-9817 is the product NDC for Terazosin hydrochloride, Terazosin hydrochloride 1 mg/1 capsule, listed with the FDA by Preferred Pharmaceuticals, Inc. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Terazosin hydrochloride.
- What is the active ingredient?
- Terazosin hydrochloride.
- Who is the labeler?
- Preferred Pharmaceuticals, Inc, NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Terazosin hydrochloride?
- 24 other product NDCs are listed under this name. See all Terazosin hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Terazosin hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-001 | 24689-0001-0124689-0001-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-002 | 24689-0002-0124689-0002-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-003 | 24689-0003-0124689-0003-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Apnar Pharma LP | 24689-004 | 24689-0004-0124689-0004-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn LLC | 87564-081 | 87564-0081-0187564-0081-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn LLC | 87564-082 | 87564-0082-0187564-0082-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Amerisyn LLC | 87564-083 | 87564-0083-0187564-0083-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Amerisyn LLC | 87564-084 | 87564-0084-0187564-0084-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-006 | 87564-0006-0187564-0006-10 |
| Terazosin Hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Amerisyn, LLC | 87564-007 | 87564-0007-0187564-0007-10 |
Other NDCs under ANDA 075317
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | AvKARE | 42291-820 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | AvKARE | 42291-821 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | AvKARE | 42291-822 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | AvKARE | 42291-823 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-0657 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-1559 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-2371 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-2623 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | AvPAK | 50268-764 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | AvPAK | 50268-765 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | AvPAK | 50268-766 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | AvPAK | 50268-767 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 1 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-383 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 2 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-384 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-385 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Jubilant Cadista Pharmaceuticals Inc. | 59746-386 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 5 mg/1 | CapsuleOral | Proficient Rx LP | 63187-456 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Proficient Rx LP | 63187-620 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-2439 |
| Terazosinterazosin hydrochloride | Terazosin hydrochloride 10 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-5237 |
Showing 20 of 39.